Welcome to our dedicated page for Zepp Health Corporation news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation stock.
Zepp Health Corporation (NYSE: ZEPP) is a leading global provider of smart wearables and health technology solutions that enable users to maximize their health, fitness, and wellness. Established in 2013 as Huami Corp., the company rebranded to Zepp Health in February 2021 to emphasize its health-centered approach. Zepp Health is renowned for its innovative brands such as Amazfit, Zepp Clarity, and Zepp Aura, which together form a comprehensive ecosystem empowering users to achieve their wellness goals.
Central to Zepp Health's offerings is the proprietary Zepp Digital Health Management Platform, which integrates advanced technologies including Zepp OS, AI chips, biometric sensors, and sophisticated data algorithms. This platform provides 24/7 actionable insights and guidance, supporting users in their everyday health and fitness journeys. To date, Zepp Health has shipped over 200 million units, with its products accessible in more than 90 countries worldwide.
Zepp Health's product portfolio is diverse, featuring smartwatches, fitness bands, and innovative devices like the Amazfit Helio Ring and Amazfit Bip 5 Unity. The company's products are designed to offer a perfect blend of style and cutting-edge technology, appealing to both professional athletes and everyday fitness enthusiasts. Notably, the Amazfit brand has garnered numerous design accolades, including the iF Design Award and the Red Dot Design Award.
Recent achievements highlight Zepp Health's commitment to excellence and community. The company has been actively involved in significant partnerships, such as sponsoring the NN Rotterdam Marathon and the Escape from Alcatraz Triathlon. Through these partnerships, Zepp Health not only promotes its high-performance wearables but also supports athletic communities worldwide.
Financially, Zepp Health reported revenues of US$39.8 million for the first quarter of 2024, with a gross margin of 36.8%. Despite a challenging market, the company's self-branded products have shown robust performance, contributing significantly to its revenue. Looking forward, Zepp Health continues to expand its product offerings and invest in strategic marketing initiatives, ensuring sustained growth and innovation.
Zepp Health's commitment to advancing health technology is further exemplified by its partnership with LiveX AI to enhance customer experiences on the Amazfit website. This collaboration utilizes AI to provide personalized and efficient customer support, setting a new standard in the industry.
For more information about Zepp Health Corporation and its innovative health technology solutions, visit www.zepp.com.
Zepp Health Corporation (NYSE: ZEPP) announced its annual general meeting (AGM) for shareholders on July 5, 2022, at 2:00 p.m. Beijing time. The meeting will not include proposals for approval but will serve as an open forum for discussions between shareholders and management. The record date for shareholders to attend is June 13, 2022. Additionally, the company filed its annual report on Form 20-F with audited financial statements for the fiscal year ending December 31, 2021, which can be accessed via their website.
Amazfit, the smart wearables brand of Zepp Health (NYSE: ZEPP), has been named the official outdoor smartwatch sponsor of the 2022 Escape from Alcatraz Triathlon. The partnership aims to support triathletes with the launch of the rugged Amazfit T-Rex 2, featuring military-grade toughness, 10 ATM water resistance, and a 24-day battery life. The smartwatch offers advanced fitness tracking, including 150+ sports modes. Amazfit will provide selected triathletes with the T-Rex 2 to monitor their performance during the race on June 5, 2022.
Amazfit, owned by Zepp Health (NYSE: ZEPP), launched the rugged outdoor GPS smartwatch Amazfit T-Rex 2 on May 24, 2022. This smartwatch features dual-band positioning, military-grade toughness, ultra-low temperature operation, and optimized route navigation for outdoor enthusiasts. Additional highlights include a battery life of up to 24 days, 10 ATM water-resistance, and support for over 150 sports modes. With a starting price of $229.99, it's now available globally and promotes health monitoring functions. The device combines stylish design with advanced outdoor capabilities, appealing to adventure seekers.
Zepp Health Corporation (NYSE: ZEPP) reported Q1 2022 revenue of RMB0.8 billion (US$119.4 million), a 34% decrease year-over-year, primarily due to decreased consumer spending and COVID-19 lockdowns in China. The company recorded a GAAP diluted net loss of RMB0.36 (US$0.06) per share, worsening from RMB0.16 in Q1 2021. Despite challenges, self-branded products accounted for over 65% of total revenue. The company launched new products and aims for net revenues of RMB1.08 billion to RMB1.30 billion in Q2 2022. As of March 31, 2022, cash reserves stood at RMB1.02 billion (US$161.2 million).
Zepp Health Corp. (NYSE: ZEPP) announced it will report its first quarter 2022 unaudited financial results before the market opens on May 24, 2022. The management will hold a conference call at 8:00 a.m. ET the same day, providing investors the opportunity to discuss results and future outlook. Zepp Health, a leader in smart wearable technology, aims to connect health with technology, having shipped 36 million units in 2021. For further details, investors can tune in to the live webcast or access a replay of the call following the event.
Zepp Health Corp. (NYSE: ZEPP) announced its identification by the SEC under the Holding Foreign Companies Accountable Act (HFCAA) on May 4, 2022. This occurred due to the use of an auditor whose working papers are not fully inspectable by the PCAOB. A company identified under HFCAA risks delisting if this continues for three consecutive years. Zepp Health is actively seeking to maintain its listing and protect stakeholder interests while complying with regulations in both China and the U.S.
Zepp Health Corp. (NYSE: ZEPP) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2021. This report can be accessed on the Company's investor relations website and the SEC's website. Zepp Health is a leader in smart health technology, providing wearable devices and health analytics services. In 2021, it shipped 36 million units globally. The Company offers free hardcopies of the annual report to shareholders upon request.
Zepp Health has released its 2021 International Sleep White Paper, analyzing data from over 26 million global users. Key findings indicate that the global average sleep duration decreased to 7h09mins. Users in Belgium reported the longest sleep at 7.5 hours, while those in Indonesia had the least at 6h36mins. About 16.3% of users nap daily, with Vietnam, China, and Spain leading in this habit. The report emphasizes the importance of sleep for health, linking active lifestyles to better sleep quality.
Zepp Health achieved significant growth in Q4 2021, ranking among the top five in global adult watch shipments, as per IDC's report. The company shipped over 6.81 million adult watches worldwide, outpacing the overall market growth. Leading in Brazil and Turkey, Zepp also secured second place in Italy, Spain, the Czech Republic, and Indonesia. CEO Wayne Huang emphasized their commitment to leveraging technology for health empowerment. The Amazfit brand is recognized for its diverse offerings, with 11 models among the top 50.
Zepp Health Corporation (NYSE: ZEPP) reported Q4 2021 revenue of RMB1.66 billion (US$260.7 million), down 15.8% from Q4 2020. Despite a year-over-year increase in shipments of Amazfit and Zepp products by 14.3%, COVID-19 impacts and semiconductor shortages hindered overall sales. Full-year revenue totaled RMB6.25 billion, a 2.8% decrease from 2020. Net income for Q4 was RMB36.3 million, a decline from RMB115.2 million a year earlier. The company announced a special dividend of US$0.025 per share and continues a share repurchase program while navigating ongoing global challenges.